TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study of the Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Ages 2 Years and Older) With Atopic Dermatitis
Brief Summary: The purpose of this study is to investigate the safety and efficacy of AN2728 Topical Ointment, 2% in children, adolescents, and adults (ages 2 years and older) with atopic dermatitis.


Options:
A: Arm Label: AN2728 Topical Ointment, 2%; Type: EXPERIMENTAL; Interventions: Drug: AN2728 Topical Ointment, 2% | Arm Label: Matching vehicle control; Type: PLACEBO_COMPARATOR; Interventions: Drug: Matching vehicle control | Intervention Type: DRUG; Name: AN2728 Topical Ointment, 2%; Assigned to Arm(s): AN2728 Topical Ointment, 2% | Intervention Type: DRUG; Name: Matching vehicle control; Assigned to Arm(s): Matching vehicle control
B: Arm Label: MEDI9929 280 mg; Type: EXPERIMENTAL; Interventions: Biological: MEDI9929 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Intervention Type: BIOLOGICAL; Name: MEDI9929; Assigned to Arm(s): MEDI9929 280 mg | Intervention Type: BIOLOGICAL; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo (for Dupilumab) | Arm Label: Dupilumab 300 mg every 2 weeks (q2w); Type: EXPERIMENTAL; Interventions: Drug: Dupilumab, Drug: Placebo (for Dupilumab) | Arm Label: Dupilumab 300 mg qw; Type: EXPERIMENTAL; Interventions: Drug: Dupilumab | Intervention Type: DRUG; Name: Dupilumab; Assigned to Arm(s): Dupilumab 300 mg every 2 weeks (q2w), Dupilumab 300 mg qw | Intervention Type: DRUG; Name: Placebo (for Dupilumab); Assigned to Arm(s): Dupilumab 300 mg every 2 weeks (q2w), Placebo
D: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Arm Label: Tralokinumab Dose 1; Type: EXPERIMENTAL; Interventions: Biological: Tralokinumab Dose 1 | Arm Label: Tralokinumab Dose 2; Type: EXPERIMENTAL; Interventions: Biological: Tralokinumab Dose 2 | Arm Label: Tralokinumab Dose 3; Type: EXPERIMENTAL; Interventions: Biological: Tralokinumab Dose 3 | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: BIOLOGICAL; Name: Tralokinumab Dose 1; Assigned to Arm(s): Tralokinumab Dose 1 | Intervention Type: BIOLOGICAL; Name: Tralokinumab Dose 2; Assigned to Arm(s): Tralokinumab Dose 2 | Intervention Type: BIOLOGICAL; Name: Tralokinumab Dose 3; Assigned to Arm(s): Tralokinumab Dose 3

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study of the Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Ages 2 Years and Older) With Atopic Dermatitis
Brief Summary: The purpose of this study is to investigate the safety and efficacy of AN2728 Topical Ointment, 2% in children, adolescents, and adults (ages 2 years and older) with atopic dermatitis.


Options:
A: Arm Label: Active Treatment 10 mg BID; Type: EXPERIMENTAL; Interventions: Drug: CP-690,550 | Arm Label: ActiveTreatment 5 mg BID; Type: EXPERIMENTAL; Interventions: Drug: CP-690,550 | Arm Label: Placebo Treatment; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo/CP-690,550 | Intervention Type: DRUG; Name: CP-690,550; Assigned to Arm(s): Active Treatment 10 mg BID | Intervention Type: DRUG; Name: CP-690,550; Assigned to Arm(s): ActiveTreatment 5 mg BID | Intervention Type: DRUG; Name: Placebo/CP-690,550; Assigned to Arm(s): Placebo Treatment | Intervention Type: DRUG; Name: Placebo/CP-690,550; Assigned to Arm(s): Placebo Treatment
B: Arm Label: AN2728 Topical Ointment, 2%; Type: EXPERIMENTAL; Interventions: Drug: AN2728 Topical Ointment, 2% | Arm Label: Matching vehicle control; Type: PLACEBO_COMPARATOR; Interventions: Drug: Matching vehicle control | Intervention Type: DRUG; Name: AN2728 Topical Ointment, 2%; Assigned to Arm(s): AN2728 Topical Ointment, 2% | Intervention Type: DRUG; Name: Matching vehicle control; Assigned to Arm(s): Matching vehicle control
C: Arm Label: AN2728 Topical Ointment, 2%; Type: EXPERIMENTAL; Interventions: Drug: AN2728 Topical Ointment, 2% | Arm Label: Matching vehicle control; Type: PLACEBO_COMPARATOR; Interventions: Drug: Matching vehicle control | Intervention Type: DRUG; Name: AN2728 Topical Ointment, 2%; Assigned to Arm(s): AN2728 Topical Ointment, 2% | Intervention Type: DRUG; Name: Matching vehicle control; Assigned to Arm(s): Matching vehicle control
D: Arm Label: Active Treatment 10 mg BID; Type: EXPERIMENTAL; Interventions: Drug: CP-690,550 | Arm Label: Active Treatment 5 mg BID; Type: EXPERIMENTAL; Interventions: Drug: CP-690,550 | Arm Label: Placebo Treatment; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo/CP-690,550 | Intervention Type: DRUG; Name: CP-690,550; Assigned to Arm(s): Active Treatment 10 mg BID | Intervention Type: DRUG; Name: CP-690,550; Assigned to Arm(s): Active Treatment 5 mg BID | Intervention Type: DRUG; Name: Placebo/CP-690,550; Assigned to Arm(s): Placebo Treatment | Intervention Type: DRUG; Name: Placebo/CP-690,550; Assigned to Arm(s): Placebo Treatment

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Systemic Pharmacokinetics Following Intravitreal Injections of Ranibizumab, Bevacizumab or Aflibercept in Patients With Neovascular Age-related Macular Degeneration
Brief Summary: Comparable data for bevacizumab and aflibercept are lacking, as are studies comparing the systemic levels of ranibizumab, bevacizumab, and aflibercept and their relative effects on circulating vascular endothelial growth factor. In the present prospective study, the investigators evaluated serum drug levels and plasma free vascular endothelial growth factor (VEGF) levels in patients with neovascular age-related macular degeneration following intravitreal injections of ranibizumab, bevacizumab and aflibercept.


Options:
A: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Drug: Ranibizumab | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Drug: Bevacizumab | Intervention Type: DRUG; Name: Ranibizumab; Assigned to Arm(s): A | Intervention Type: DRUG; Name: Bevacizumab; Assigned to Arm(s): B
B: Intervention Type: DRUG; Name: rhuFab V2 (ranibizumab); Assigned to Arm(s): N/A
C: Arm Label: Aflibercept Blood Sample Collection; Type: ACTIVE_COMPARATOR; Interventions: Biological: Blood Sample Collection, Drug: Aflibercept | Arm Label: Bevacizumab Blood Sample Collection; Type: ACTIVE_COMPARATOR; Interventions: Biological: Blood Sample Collection, Drug: Bevacizumab | Arm Label: Ranibizumab Blood Sample Collection; Type: ACTIVE_COMPARATOR; Interventions: Biological: Blood Sample Collection, Drug: Ranibizumab | Intervention Type: BIOLOGICAL; Name: Blood Sample Collection; Assigned to Arm(s): Aflibercept Blood Sample Collection, Bevacizumab Blood Sample Collection, Ranibizumab Blood Sample Collection | Intervention Type: DRUG; Name: Aflibercept; Assigned to Arm(s): Aflibercept Blood Sample Collection | Intervention Type: DRUG; Name: Bevacizumab; Assigned to Arm(s): Bevacizumab Blood Sample Collection | Intervention Type: DRUG; Name: Ranibizumab; Assigned to Arm(s): Ranibizumab Blood Sample Collection
D: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: ranibizumab | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: bevacizumab | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Drug: ranibizumab | Arm Label: 4; Type: EXPERIMENTAL; Interventions: Drug: bevacizumab | Intervention Type: DRUG; Name: ranibizumab; Assigned to Arm(s): 1, 3 | Intervention Type: DRUG; Name: bevacizumab; Assigned to Arm(s): 2, 4

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Clinical Trial Comparing Conventional Laparoscopic and Robot-Assisted Laparoscopic Hysterectomy
Brief Summary: Robotic-assisted surgery is becoming more prominent within the specialty of Gynecologic surgery with little direct evidence that it is if not better than traditional laparoscopic surgery, at least equivalent. We designed a randomized-controlled trial to compare operative times, length of hospital stay, estimated blood loss, and post-operative complications associated with these two methods of minimally invasive hysterectomy.


Options:
A: Arm Label: Robot assisted laparoscopic hysterectomy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Robot assisted laparoscopic hysterectomy | Arm Label: Abdominal hysterectomy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Abdominal hysterectomy | Intervention Type: PROCEDURE; Name: Abdominal hysterectomy; Assigned to Arm(s): Abdominal hysterectomy | Intervention Type: PROCEDURE; Name: Robot assisted laparoscopic hysterectomy; Assigned to Arm(s): Robot assisted laparoscopic hysterectomy
B: Arm Label: VH; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Vaginal hysterectomy | Arm Label: LAVH; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Laparoscopic assisted vaginal hysterectomy | Intervention Type: PROCEDURE; Name: Vaginal hysterectomy; Assigned to Arm(s): VH | Intervention Type: PROCEDURE; Name: Laparoscopic assisted vaginal hysterectomy; Assigned to Arm(s): LAVH
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Conventional Laparoscopic Hysterectomy | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Robot-assisted (Da Vinci®) laparoscopic hysterectomy | Intervention Type: PROCEDURE; Name: Conventional Laparoscopic Hysterectomy; Assigned to Arm(s): 1 | Intervention Type: PROCEDURE; Name: Robot-assisted (Da Vinci®) laparoscopic hysterectomy; Assigned to Arm(s): 2
D: Arm Label: Robot-assisted; Type: EXPERIMENTAL; Interventions: Procedure: Hysterectomy | Arm Label: Laparoscopic Hysterectomy; Type: EXPERIMENTAL; Interventions: Procedure: Hysterectomy | Intervention Type: PROCEDURE; Name: Hysterectomy; Assigned to Arm(s): Laparoscopic Hysterectomy, Robot-assisted

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Clinical Trial Comparing Conventional Laparoscopic and Robot-Assisted Laparoscopic Hysterectomy
Brief Summary: Robotic-assisted surgery is becoming more prominent within the specialty of Gynecologic surgery with little direct evidence that it is if not better than traditional laparoscopic surgery, at least equivalent. We designed a randomized-controlled trial to compare operative times, length of hospital stay, estimated blood loss, and post-operative complications associated with these two methods of minimally invasive hysterectomy.


Options:
A: Arm Label: Robotic surgery; Type: EXPERIMENTAL; Interventions: Procedure: Robotic surgery | Arm Label: Abdominal surgery; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Abdominal surgery | Intervention Type: PROCEDURE; Name: Robotic surgery; Assigned to Arm(s): Robotic surgery | Intervention Type: PROCEDURE; Name: Abdominal surgery; Assigned to Arm(s): Abdominal surgery
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Total Abdominal Radical Hysterectomy | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Procedure: Total Laparoscopic or Robotic Radical Hysterectomy | Intervention Type: PROCEDURE; Name: Total Abdominal Radical Hysterectomy; Assigned to Arm(s): 1 | Intervention Type: PROCEDURE; Name: Total Laparoscopic or Robotic Radical Hysterectomy; Assigned to Arm(s): 2
C: Arm Label: Robot-assisted; Type: EXPERIMENTAL; Interventions: Procedure: Hysterectomy | Arm Label: Laparoscopic Hysterectomy; Type: EXPERIMENTAL; Interventions: Procedure: Hysterectomy | Intervention Type: PROCEDURE; Name: Hysterectomy; Assigned to Arm(s): Laparoscopic Hysterectomy, Robot-assisted
D: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Conventional Laparoscopic Hysterectomy | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Robot-assisted (Da Vinci®) laparoscopic hysterectomy | Intervention Type: PROCEDURE; Name: Conventional Laparoscopic Hysterectomy; Assigned to Arm(s): 1 | Intervention Type: PROCEDURE; Name: Robot-assisted (Da Vinci®) laparoscopic hysterectomy; Assigned to Arm(s): 2

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Biomarkers of Orthodontic Tooth Movement With Fixed Appliances and Vibration Appliance Therapy: A Randomized Clinical Trial
Brief Summary: Currently, orthodontic treatment typically lasts approximately 2 years. There are a number of advantages for reducing the duration of treatment, including reducing the potential risk of caries, root resorption and for minimizing patient "burn out" from prolonged treatment.

While some evidence does exist that vibration may accelerate the speed of tooth movement, the biological mechanism is still unknown. Identification of specific factors involved in tooth movement that are further stimulated by vibration would help to understand the mechanisms involved as well as discover possible biologic targets which could be utilized or modified to maximize the benefits of vibration treatment.

The purpose of this study is to identify novel biological factors that are expressed in patients undergoing orthodontic tooth movement in conjunction with vibration appliance therapy.


Options:
A: Arm Label: AcceleDent vibrational device; Type: EXPERIMENTAL; Interventions: Device: AcceleDent vibrational device | Arm Label: Sham AcceleDent device; Type: SHAM_COMPARATOR; Interventions: Device: Sham AcceleDent device | Arm Label: Fixed appliance only; Type: ACTIVE_COMPARATOR; Interventions: Other: Fixed appliance only | Intervention Type: DEVICE; Name: AcceleDent vibrational device; Assigned to Arm(s): AcceleDent vibrational device | Intervention Type: DEVICE; Name: Sham AcceleDent device; Assigned to Arm(s): Sham AcceleDent device | Intervention Type: OTHER; Name: Fixed appliance only; Assigned to Arm(s): Fixed appliance only
B: Arm Label: Conventional Decrowding; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Low Level Laser Therapy; Type: EXPERIMENTAL; Interventions: Radiation: low level laser therapy | Intervention Type: RADIATION; Name: low level laser therapy; Assigned to Arm(s): Low Level Laser Therapy
C: Arm Label: Vibration Device+Fixed Appliance Tx; Type: EXPERIMENTAL; Interventions: Device: Vibration Device | Arm Label: No Vibration Device+Fixed Appliance Tx; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Vibration Device; Assigned to Arm(s): Vibration Device+Fixed Appliance Tx
D: Arm Label: 0.018 bracket slot system; Type: EXPERIMENTAL; Interventions: Device: Orthodontic bracket slot system | Arm Label: 0.022 bracket slot system; Type: ACTIVE_COMPARATOR; Interventions: Device: Orthodontic bracket slot system | Intervention Type: DEVICE; Name: Orthodontic bracket slot system; Assigned to Arm(s): 0.018 bracket slot system, 0.022 bracket slot system

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Investigating the Effects of a Psycho-educational Support Group Therapy on Cancer Caregivers' Burden and Quality of Life
Brief Summary: This is a study to determine the effectiveness of a Group Therapy that provides psycho-education and support for caregivers of cancer patients. Caregivers must be between 21 and 64 years of age and be willing to attend a one-hour a week program for four weeks. The sessions will be in English, and a set of questionnaires (demographic data, some information about your family member with cancer, and scales: Caregiver Quality of Life-Cancer Scale (CQOLC), Perceived Stress Scale and the Hospital Anxiety Depression Scale (HADS)) will be completed at the start, at 4 weeks, at 8 weeks and at 12 weeks. Some participants placed on a wait-list to start the Group Therapy 4 weeks later will also complete the set of questionnaires at this point. A Feedback and Satisfaction Questionnaire will be completed at the end of the 4 week program. In addition, at the end of the 4 week program, some participants will go through a 15-minute interview.


Options:
A: Arm Label: Brief; Type: EXPERIMENTAL; Interventions: Behavioral: Brief FOCUS Program | Arm Label: Extensive; Type: EXPERIMENTAL; Interventions: Behavioral: Extensive FOCUS Program | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Brief FOCUS Program; Assigned to Arm(s): Brief | Intervention Type: BEHAVIORAL; Name: Extensive FOCUS Program; Assigned to Arm(s): Extensive
B: Arm Label: Self-Efficacy Training for Caregivers; Type: OTHER; Interventions: Other: Self-Efficacy Training for Caregivers | Arm Label: Comparison Conditions for Caregivers; Type: OTHER; Interventions: Other: Comparison Conditions for Caregivers | Intervention Type: OTHER; Name: Self-Efficacy Training for Caregivers; Assigned to Arm(s): Self-Efficacy Training for Caregivers | Intervention Type: OTHER; Name: Comparison Conditions for Caregivers; Assigned to Arm(s): Comparison Conditions for Caregivers
C: Arm Label: Psychological Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Psychological intervention | Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Psychological intervention; Assigned to Arm(s): Psychological Intervention
D: Arm Label: Psycho-educational support group therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Psycho-educational support group therapy | Intervention Type: BEHAVIORAL; Name: Psycho-educational support group therapy; Assigned to Arm(s): Psycho-educational support group therapy

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effect of Varied Intensities of Breastfeeding Peer Support on Duration of Breastfeeding Among Oregon WIC Participants
Brief Summary: The U.S. Surgeon General has recommended that peer counseling to support breastfeeding become a core service of the Supplemental Nutrition Program for Women, Infants and Children (WIC). As of 2008, 50 percent of WIC clients received services from local WIC agencies that offered peer counseling. Little is known as to the effectiveness of these peer counseling programs. Randomized controlled trials of peer counseling interventions among low-income women in the U.S. showed increases in breastfeeding initiation and duration, but it is doubtful that the level of support provided could be scaled up to service WIC clients nationally. The investigators tested whether a telephone peer counseling program among WIC participants could increase breastfeeding initiation, duration and exclusivity.


Options:
A: Arm Label: Home-based counselling visits by volunteers; Type: EXPERIMENTAL; Interventions: Behavioral: Home-based counselling | Arm Label: Standard care through existing health system; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Home-based counselling; Assigned to Arm(s): Home-based counselling visits by volunteers
B: Arm Label: implementation strategy; Type: EXPERIMENTAL; Interventions: Other: implementation strategy of Breastfeeding | Arm Label: Conventional intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: implementation strategy of Breastfeeding; Assigned to Arm(s): implementation strategy
C: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Low Intensity; Type: OTHER; Interventions: Other: Telephone-based breastfeeding peer counseling | Arm Label: High Intensity; Type: ACTIVE_COMPARATOR; Interventions: Other: Telephone-based breastfeeding peer counseling | Intervention Type: OTHER; Name: Telephone-based breastfeeding peer counseling; Assigned to Arm(s): High Intensity, Low Intensity
D: Intervention Type: BEHAVIORAL; Name: Home Nurse Visit; Assigned to Arm(s): N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effect of Varied Intensities of Breastfeeding Peer Support on Duration of Breastfeeding Among Oregon WIC Participants
Brief Summary: The U.S. Surgeon General has recommended that peer counseling to support breastfeeding become a core service of the Supplemental Nutrition Program for Women, Infants and Children (WIC). As of 2008, 50 percent of WIC clients received services from local WIC agencies that offered peer counseling. Little is known as to the effectiveness of these peer counseling programs. Randomized controlled trials of peer counseling interventions among low-income women in the U.S. showed increases in breastfeeding initiation and duration, but it is doubtful that the level of support provided could be scaled up to service WIC clients nationally. The investigators tested whether a telephone peer counseling program among WIC participants could increase breastfeeding initiation, duration and exclusivity.


Options:
A: Arm Label: Community behaviour change campaign; Type: EXPERIMENTAL; Interventions: Behavioral: Community behaviour change campaign | Arm Label: No community behaviour change campaign; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Community behaviour change campaign; Assigned to Arm(s): Community behaviour change campaign
B: Arm Label: Breastfeeding Education and Support; Type: EXPERIMENTAL; Interventions: Behavioral: Breastfeeding Education and Support | Arm Label: Usual or routine care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Breastfeeding Education and Support; Assigned to Arm(s): Breastfeeding Education and Support
C: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Low Intensity; Type: OTHER; Interventions: Other: Telephone-based breastfeeding peer counseling | Arm Label: High Intensity; Type: ACTIVE_COMPARATOR; Interventions: Other: Telephone-based breastfeeding peer counseling | Intervention Type: OTHER; Name: Telephone-based breastfeeding peer counseling; Assigned to Arm(s): High Intensity, Low Intensity
D: Arm Label: A; Type: EXPERIMENTAL; Interventions: Other: Telephone Support Intervention to Improve Breastfeeding | Arm Label: B; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Telephone Support Intervention to Improve Breastfeeding; Assigned to Arm(s): A

Answer: C